Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far.

The pharma sector is likely to maintain steady earnings. Most brokerages flag US business recovery as the key swing factor ...

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Sun Pharmaceutical Industries Ltd. closed 13.65% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Sun Pharmaceuticals is one of India’s largest pharmaceutical companies with over 8% share in the domestic market. It owns 35 ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Nifty Pharma index sinks over 2% as Indian drugmakers face tariff heat; Gland, Aurobindo, Biocon, Sun Pharma among top losers ...